Project Grant R21DA062071

Award Date 6/15/25
Completion Date 5/31/27
Dollars Obligated $219K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Rhode Island, USA
Similar Awards
The National Institutes of Health's National Institute on Drug Abuse awarded New York University School of Medicine a $1,446,310 Project Grant under the Drug Abuse and Addiction Research Programs to adapt an evidence-based posttraumatic stress disorder intervention for polysubstance use populations receiving treatment for opioid use disorder. Specifically, the award will support adapting an existing trauma-focused therapy, Skills Training in Affective and Interpersonal Regulation with...
This Project Grant, award ID R61DA061371, is funded by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The $1,826,522 award will support the development and implementation of a digital, decision-support toolkit to address intimate partner violence (IPV), posttraumatic stress disorder (PTSD), and opioid use disorder (OUD) in opioid treatment programs. The project includes three aims: 1) conducting stakeholder interviews to...
This federal Project Grant award of $663,662 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to deliver an evidence-based, trauma-informed substance use prevention intervention for youth in foster care. The grant, awarded to Iowa State University, will first adapt existing evidence-based interventions to be tailored for the unique needs of youth in foster care. The adapted intervention, called the CASA Brief Intervention...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $196,560 to the Regents of the University of Michigan to conduct research aimed at identifying neurosignatures predictive of problematic substance use in adolescents, investigating the links between specific types of childhood trauma and aberrant neurocircuits, and assessing the ability of adolescents to modulate these neurosignatures using...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,717,104 to adapt, produce, and pilot test a youth overdose prevention "toolkit" for use in pediatric healthcare settings. The toolkit will be developed through a community-engaged approach in Boston, MA and Vancouver, BC, two locations heavily impacted by the overdose crisis. It will provide clinicians with practical guidance on...
The National Institute on Drug Abuse (NIDA) awarded a $264,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Innovation Research And Training, Inc. (IRT), a woman-owned small business research organization based in Durham, North Carolina. The purpose of this 3-year project, beginning September 2024, is to evaluate the "Substance of Change: Building Assets in Mentees Affected by Substance Misuse" (SOC), an interactive, multimedia, web-based,...
The National Institute on Drug Abuse (NIDA) awarded a $672,206 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Texas Health Science Center at Houston (UTHealth) to develop an enhanced model of sexual assault nurse examiner (SANE) services that integrates HIV prevention and substance use treatment for adolescents and young adults (AYAs) who have experienced sexual violence. The key goals of the three-year project are to: 1) tailor existing...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and evaluate a technology-based intervention to encourage protective behaviors against drug overdose, such as drug checking, distribution of harm reduction supplies, and linkage to services. The total award amount is $1,607,146 over a 2-year period from September 2024 to August 2026. The project will be led by the non-profit organization...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a research project entitled "Optimizing Developmental Outcomes in Early Childhood After Neonatal Opioid Withdrawal Syndrome." The $180,059 award, effective August 1, 2024, will fund a 5-year longitudinal study to assess the independent and moderating effects of positive childhood experiences (PCEs) and adverse childhood experiences...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $280,207 to develop "A Digital Intervention to Reduce Youth Cannabis Use." The project aims to create a novel mobile application and SMS-based platform tailored for youth ages 13-17 who are regular cannabis users. The intervention will offer personalized feedback, daily communications, guided meditations, multimedia content, and...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and pilot test an intervention called the Adolescent Stress and Substance Intervention Subsequent to Trauma (ASSIST) video intervention. The $219,020 grant will be used to: 1) Develop and refine two ASSIST video interventions, in English and Spanish, for adolescent trauma patients (12-17 years) and their parents admitted to a Level 1 pediatric trauma center, and 2) Evaluate the feasibility, acceptability, and implementation potential of the ASSIST video interventions through a pilot test with 30 adolescent trauma patients and their parents. The goal is to improve mental health screening and intervention within pediatric trauma centers to address trauma-related sequelae, including post-traumatic stress disorder and substance use/misuse, following patient discharge. The grant period runs from June 15, 2025 to May 31, 2027.

Generated 7/1/25, 2:44 AM